|
Volumn 16, Issue 1, 2010, Pages 18-22
|
Treatment of premature ovarian failure trial: Description of an ongoing clinical trial
|
Author keywords
combined oral contraceptive pill; early menopause; hormone replacement therapy; osteoporosis; Premature ovarian failure
|
Indexed keywords
ESTRADIOL;
ESTRADIOL VALERATE PLUS NORGESTREL;
ETHINYLESTRADIOL PLUS LEVONORGESTREL;
LEVONORGESTREL;
ADULT;
ARTICLE;
BONE SCINTISCANNING;
CARDIOVASCULAR DISEASE;
CLINICAL FEATURE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
DISEASE MARKER;
ESTROGEN THERAPY;
EVIDENCE BASED PRACTICE;
FEMALE;
HEALTH HAZARD;
HUMAN;
MAJOR CLINICAL STUDY;
PREMATURE OVARIAN FAILURE;
RANDOMIZED CONTROLLED TRIAL;
SYMPTOM;
TREATMENT OUTCOME;
ADOLESCENT;
ADULT;
BONE DENSITY;
CONTRACEPTIVES, ORAL, COMBINED;
CONTRACEPTIVES, ORAL, SYNTHETIC;
ESTRADIOL;
ESTROGEN REPLACEMENT THERAPY;
ESTROGENS;
ETHINYL ESTRADIOL;
FEMALE;
HUMANS;
LEVONORGESTREL;
OVARIAN FAILURE, PREMATURE;
PROSPECTIVE STUDIES;
TREATMENT OUTCOME;
YOUNG ADULT;
|
EID: 77951714996
PISSN: 17540453
EISSN: 17540461
Source Type: Journal
DOI: 10.1258/mi.2010.010010 Document Type: Article |
Times cited : (16)
|
References (8)
|